Skip to main content

Advertisement

SpringerLink
Log in

Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer

  • Brief Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Weight gain in women receiving chemotherapy for breast cancer is associated with a higher risk of recurrence. Using metabonomic profiling, we recently reported that plasma lactate and alanine were prognostic for weight gain in individuals with breast cancer receiving chemotherapy. The role of lipid second messengers has not been studied. We assessed serum levels of sphingosine-1-phosphate (S1P), a known secreted lipid second messenger with a role in cell growth, in sequential samples from post-menopausal women receiving standard chemotherapy for early breast cancer and correlated these with body mass measurements and metabonomic profiling. While serum S1P levels prior to treatment did not correlate with body weight changes or circulating alanine and lactate, S1P levels measured during therapy were inversely correlated with weight gain (P = 0.04), but not weight loss (P = 0.74) or no change in weight (P = 0.5), suggesting a role of dynamic circulating S1P in adipocyte growth. These data provide evidence for an association between serum S1P and weight gain during chemotherapy cycles in women with breast cancer. Lipid second messengers have a role in chemotherapy-induced weight gain in breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, Stefanick ML, Faerber S, Pierce JP (1999) Factors associated with weight gain in women after diagnosis of breast cancer. Women’s Healthy Eating and Living Study Group. J Am Diet Assoc 99(10):1212–1221

    Article  CAS  PubMed  Google Scholar 

  2. Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK, Blackwell K, Rimer BK (2001) Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19(9):2381–2389

    Article  CAS  PubMed  Google Scholar 

  3. Dixon JK, Moritz DA, Baker FL (1978) Breast cancer and weight gain: an unexpected finding. Oncol Nurs Forum 5(3):5–7

    CAS  PubMed  Google Scholar 

  4. Donegan WL, Hartz AJ, Rimm AA (1978) The association of body weight with recurrent cancer of the breast. Cancer 41(4):1590–1594

    Article  CAS  PubMed  Google Scholar 

  5. Huntington MO (1985) Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer 56(3):472–474

    Article  CAS  PubMed  Google Scholar 

  6. Goodwin PJ (2001) Weight gain in early-stage breast cancer: where do we go from here? J Clin Oncol 19(9):2367–2369

    Article  CAS  PubMed  Google Scholar 

  7. Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20(4):1128–1143

    Article  PubMed  Google Scholar 

  8. Kroenke CH, Chen WY, Rosner B, Holmes MD (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23(7):1370–1378

    Article  PubMed  Google Scholar 

  9. Caan BJ, Emond JA, Natarajan L, Castillo A, Gunderson EP, Habel L, Jones L, Newman VA, Rock CL, Slattery ML et al (2006) Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat 99(1):47–57

    Article  PubMed  Google Scholar 

  10. Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M, Mahabir S, Hortobagyi GN, Brewster AM (2008) Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 26(25):4072–4077

    Article  PubMed  PubMed Central  Google Scholar 

  11. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, Goodman MT, Giuliano AE, Karanja N, McAndrew P et al (2006) Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst 98(24):1767–1776

    Article  PubMed  Google Scholar 

  12. Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, Al-Delaimy WK, Thomson CA, Kealey S, Hajek R et al (2007) Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 25(17):2345–2351

    Article  PubMed  Google Scholar 

  13. Keun HC, Sidhu J, Pchejetski D, Lewis JS, Marconell H, Patterson M, Bloom SR, Amber V, Coombes RC, Stebbing J (2009) Serum molecular signatures of weight change during early breast cancer chemotherapy. Clin Cancer Res 15(21):6716–6723

    Article  CAS  PubMed  Google Scholar 

  14. Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4(8):604–616

    Article  CAS  PubMed  Google Scholar 

  15. Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, Spiegel S (2006) Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci USA 103(44):16394–16399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hla T (2003) Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res 47(5):401–407

    Article  CAS  PubMed  Google Scholar 

  17. Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ (2001) Lysophospholipids–receptor revelations. Science 294(5548):1875–1878

    Article  CAS  PubMed  Google Scholar 

  18. Payne SG, Milstien S, Spiegel S (2002) Sphingosine-1-phosphate: dual messenger functions. FEBS Lett 531(1):54–57

    Article  CAS  PubMed  Google Scholar 

  19. Xia P, Gamble JR, Rye KA, Wang L, Hii CS, Cockerill P, Khew-Goodall Y, Bert AG, Barter PJ, Vadas MA (1998) Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc Natl Acad Sci USA 95(24):14196–14201

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Pettus BJ, Bielawski J, Porcelli AM, Reames DL, Johnson KR, Morrow J, Chalfant CE, Obeid LM, Hannun YA (2003) The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. Faseb J 17(11):1411–1421

    Article  CAS  PubMed  Google Scholar 

  21. Sato K, Ishikawa K, Ui M, Okajima F (1999) Sphingosine 1-phosphate induces expression of early growth response-1 and fibroblast growth factor-2 through mechanism involving extracellular signal-regulated kinase in astroglial cells. Brain Res 74(1–2):182–189

    CAS  Google Scholar 

  22. Bayerl MG, Bruggeman RD, Conroy EJ, Hengst JA, King TS, Jimenez M, Claxton DF, Yun JK (2008) Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions. Leuk Lymphoma 49(5):948–954

    Article  CAS  PubMed  Google Scholar 

  23. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, Smith CD (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63(18):5962–5969

    CAS  PubMed  Google Scholar 

  24. Ruckhäberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, Grösch S, Geisslinger G, Holtrich U, Karn T, Kaufmann M (2008) Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat 112(1):41–52

    Article  PubMed  Google Scholar 

  25. Van Brocklyn JR, Jackson CA, Pearl DK, Kotur MS, Snyder PJ, Prior TW (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol 64(8):695–705

    Article  PubMed  Google Scholar 

  26. Li J, Guan HY, Gong LY, Song LB, Zhang N, Wu J, Yuan J, Zheng YJ, Huang ZS, Li M (2008) Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res 14(21):6996–7003

    Article  CAS  PubMed  Google Scholar 

  27. Li W, Yu CP, Xia JT, Zhang L, Weng GX, Zheng HQ, Kong QL, Hu LJ, Zeng MS, Zeng YX et al (2009) Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 15(4):1393–1399

    Article  CAS  PubMed  Google Scholar 

  28. English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN, Garcia JG (2000) Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. Faseb J 14(14):2255–2265

    Article  CAS  PubMed  Google Scholar 

  29. Yatomi Y, Ohmori T, Rile G, Kazama F, Okamoto H, Sano T, Satoh K, Kume S, Tigyi G, Igarashi Y et al (2000) Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 96(10):3431–3438

    Article  CAS  PubMed  Google Scholar 

  30. Hanel P, Andreani P, Graler MH (2007) Erythrocytes store and release sphingosine 1-phosphate in blood. Faseb J 21(4):1202–1209

    Article  PubMed  Google Scholar 

  31. Ohkawa R, Nakamura K, Okubo S, Hosogaya S, Ozaki Y, Tozuka M, Osima N, Yokota H, Ikeda H, Yatomi Y (2008) Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters. Ann Clin Biochem 45(Pt 4):356–363

    Article  CAS  PubMed  Google Scholar 

  32. Deutschman DH, Carstens JS, Klepper RL, Smith WS, Page MT, Young TR, Gleason LA, Nakajima N, Sabbadini RA (2003) Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J 146(1):62–68

    Article  CAS  PubMed  Google Scholar 

  33. Kawamori T, Osta W, Johnson KR, Pettus BJ, Bielawski J, Tanaka T, Wargovich MJ, Reddy BS, Hannun YA, Obeid LM et al (2006) Sphingosine kinase 1 is up-regulated in colon carcinogenesis. Faseb J 20(2):386–388

    Article  CAS  PubMed  Google Scholar 

  34. Sutphen R, Xu Y, Wilbanks GD, Fiorica J, Grendys EC Jr, LaPolla JP, Arango H, Hoffman MS, Martino M, Wakeley K et al (2004) Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol Biomarkers Prev 13(7):1185–1191

    Article  CAS  PubMed  Google Scholar 

  35. Boneva-Asiova Z, Boyanov MA (2008) Body composition analysis by leg-to-leg bioelectrical impedance and dual-energy X-ray absorptiometry in non-obese and obese individuals. Diabetes Obes Metab 10(11):1012–1018

    Article  CAS  PubMed  Google Scholar 

  36. Edsall LC, Spiegel S (1999) Enzymatic measurement of sphingosine 1-phosphate. Anal Biochem 272(1):80–86

    Article  CAS  PubMed  Google Scholar 

  37. Pchejetski D, Doumerc N, Golzio M, Naymark M, Teissie J, Kohama T, Waxman J, Malavaud B, Cuvillier O (2008) Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol Cancer Ther 7(7):1836–1845

    Article  CAS  PubMed  Google Scholar 

  38. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226(1):497–509

    Article  CAS  PubMed  Google Scholar 

  39. Pchejetski D, Golzio M, Bonhoure E, Calvet C, Doumerc N, Garcia V, Mazerolles C, Rischmann P, Teissie J, Malavaud B et al (2005) Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res 65(24):11667–11675

    Article  CAS  PubMed  Google Scholar 

  40. Pischon T, Nothlings U, Boeing H (2008) Obesity and cancer. Proc Nutrition Soc 67(2):128–145

    Article  Google Scholar 

  41. Vona-Davis L, Rose DP (2009) Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev 20(3):193–201

    Article  CAS  PubMed  Google Scholar 

  42. Takabe K, Paugh SW, Milstien S, Spiegel S (2008) “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 60(2):181–195

    Article  CAS  PubMed  Google Scholar 

  43. Bonhoure E, Pchejetski D, Aouali N, Morjani H, Levade T, Kohama T, Cuvillier O (2006) Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 20(1):95–102

    Article  CAS  PubMed  Google Scholar 

  44. Sauer L, Nunes J, Salunkhe V, Skalska L, Kohama T, Cuvillier O, Waxman J, Pchejetski D (2009) Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. Int J Cancer 125(11):2728–2736

    Article  CAS  PubMed  Google Scholar 

  45. Guillermet-Guibert J, Davenne L, Pchejetski D, Saint-Laurent N, Brizuela L, Guilbeau-Frugier C, Delisle MB, Cuvillier O, Susini C, Bousquet C (2009) Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. Mol Cancer Ther 8(4):809–820

    Article  CAS  PubMed  Google Scholar 

  46. Gude DR, Alvarez SE, Paugh SW, Mitra P, Yu J, Griffiths R, Barbour SE, Milstien S, Spiegel S (2008) Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a “come-and-get-me” signal. Faseb J 22(8):2629–2638

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Jun DJ, Lee JH, Choi BH, Koh TK, Ha DC, Jeong MW, Kim KT (2006) Sphingosine-1-phosphate modulates both lipolysis and leptin production in differentiated rat white adipocytes. Endocrinology 147(12):5835–5844

    Article  CAS  PubMed  Google Scholar 

  48. Jobgen W, Fu WJ, Gao H, Li P, Meininger CJ, Smith SB, Spencer TE, Wu G (2009) High fat feeding and dietary l-arginine supplementation differentially regulate gene expression in rat white adipose tissue. Amino Acids 37(1):187–198

    Article  CAS  PubMed  Google Scholar 

  49. Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS et al (2006) Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9(3):225–238

    Article  CAS  PubMed  Google Scholar 

  50. Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G et al (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Eng J Med 362(5):402–415

    Article  Google Scholar 

  51. Kappos L, Radue EW, O’Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L et al (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Eng J Med 362(5):387–401

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by The Royal Society (Grant number P24841 to DP), The Prostate Cancer Charity (Grant number 110630 to DP), and Prostate UK (Grant number G2007/07 to DP). JS is supported by Ovarian Cancer Action.

Author information

Authors and Affiliations

  1. Department of Surgery and Cancer, Imperial College, London, UK

    Dmitri Pchejetski, Joao Nunes, Lysann Sauer, Jonathan Waxman & Justin Stebbing

  2. Biomolecular Medicine, Department of Surgery and Cancer, Imperial College, London, UK

    Jasmin Sidhu, Anand Sharma & Hector C. Keun

  3. Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, 807, Cyclotron Building, Ducane Road, W120NN, London, UK

    Dmitri Pchejetski

  4. Imperial College Healthcare NHS Trust, Charing Cross Hospital, 1st Floor, E Wing, Fulham Palace Road, London, W6 8RF, UK

    Justin Stebbing

Authors
  1. Dmitri Pchejetski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joao Nunes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lysann Sauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jasmin Sidhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anand Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hector C. Keun
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jonathan Waxman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Justin Stebbing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Dmitri Pchejetski or Justin Stebbing.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 14 kb)

Following files are unfortunately not in the Publisher's archive anymore:

  • Supplementary material 2 (tiff 96 kb)

  • Supplementary material 3 (tiff 80 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pchejetski, D., Nunes, J., Sauer, L. et al. Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer. Breast Cancer Res Treat 124, 543–549 (2010). https://doi.org/10.1007/s10549-010-0968-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-0968-y

Keywords

Search

Navigation